Professor Jörg Huwyler is a leading specialist in targeted drug delivery, member of the Swiss Academy of Pharmaceutical Sciences, author of 13 patents, 142 peer-reviewed scientific articles (h-index: 38). One of his innovative publications on the delivery of antitumor agents to the rat brain due to immunoliposomes has been cited more than 650 times.
The expert calls the pharmaceutical technology a translation science, as it very often helps to transfer the results of basic research to clinical applications. Several drugs developed in his Swiss laboratory are used in clinical trials.
The joint team of the scientific laboratory for the study of innovative methods of drug delivery is already participating in the project to increase the bioavailability of the drug for the treatment of AIDS by using hot melt extrusion.
The work is also carried out in the field of creating a combined diagnostic drug that will enable drugs adequate choice and dosage regimen in the treatment of cancer.
One of the goals of RUDN research is the development of individual approaches in the treatment of cancer patients through the use of innovative pharmaceutical technologies and metabolic tools - the transition to personalized medicine.
On February 19, in 2017, Nikolai Sergeyevich Prostakov would have turned 100 years old.
Dear entrants, students and alumni, meet the English-speaking channel in YouTube
2 March, RUDN chose the King of Africa or Mister RUDN Association of African students – Zim Sankvella (SAR), first-year student of the Agrarian and Technological Institute who won over students from Cameroon, Chad, Namibia, Angola, Ethiopia and SAR. Vice-Mister was Binga Medesh (Angola), third place was taken by Naftalu Kuume (Namibia).